Risk factors for klebsiella pneumoniae carbapenemase-producing klebsiella pneumoniae colonization in neonates

Chinese Journal of Contemporary Pediatrics

Volumn 16, Issue 10, 2014, Pages 970-974

  Ma, Ming Sheng ^a   Wang, Dan Hua ^a   Sun, Xiu Jing ^a   Li, Zheng Hong ^a   Wang, Chen ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Carbapenems; Colonization; Klebsiella pneumoniae; Neonate

Indexed keywords

CARBAPENEM DERIVATIVE; CARBAPENEMASE; GLYCOPEPTIDE; BACTERIAL PROTEIN; BETA LACTAMASE;

ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL COLONIZATION; BIRTH WEIGHT; CASE CONTROL STUDY; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; DRUG EXPOSURE; GESTATIONAL AGE; HOSPITALIZATION; HUMAN; INTRAVENOUS FEEDING; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE CARBAPENEMASE PRODUCING KLEBSIELLA PNEUMONIAE; LENGTH OF STAY; NEWBORN; NEWBORN DISEASE; NEWBORN INTENSIVE CARE; PERIPHERALLY INSERTED CENTRAL VENOUS CATHETER; RISK FACTOR; TREATMENT DURATION; BIOSYNTHESIS; ENZYMOLOGY; FEMALE; ISOLATION AND PURIFICATION; MALE; STATISTICAL MODEL;

BACTERIAL PROTEINS; BETA-LACTAMASES; CARBAPENEMS; FEMALE; HUMANS; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; KLEBSIELLA PNEUMONIAE; LOGISTIC MODELS; MALE; RISK FACTORS;

EID: 84911031535     PISSN: 10088830     EISSN: None     Source Type: Journal    
DOI: 10.7499/j.issn.1008-8830.2014.10.002     Document Type: Article

References (14)

1. Yigit H, Queenan AM, Anderson GJ, et al. Novel carbapenemhydrolyzing beta-lactamase, KPC-1, from a carbapenemresistant strain of Klebsiella pneumoniae [J]. Antimicrob Agents Chemother, 2001, 45(4): 1151-1161.
2. Borer A, Saidel-Odes L, Eskira S, et al. Risk factors for developing clinical infection with carbapenem-resistant Klebsiella pneumoniae in hospital patients initially only colonized with carbapenem-resistant K. pneumonia[J]. Am J Infect Control, 2012, 40(5): 421-425.
3. Clinical and Laboratory Standards Institute (CLSI). M100-S20-Performance standards for antimicrobial susceptibility testing[S]. 2010.
4. Carvalhaes CG, Picão RC, Nicoletti AG, et al. Cloverleaf test (modified Hodge test) for detecting carbapenemase production in Klebsiella pneumoniae: be aware of false positive results[J]. J Antimicrob Chemother, 2010, 65(2): 249-251.
5. Hidron AI, Edwards JR, Patel J, et al. NHSN annual update: Antimicrobial-resistant pathogens associated with healthcareassociated infections: Annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007[J]. Infect Control Hosp Epidemiol, 2008, 29(11): 996-1011.
6. Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumonia carbapenemase-producing bacteria [J]. Lancet Infect Dis, 2009, 9(4): 228-236.
7. Schwaber MJ, Klarfeld-Lidji S, Navon-Venezia S, et al. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality[J]. Antimicrob Agents Chemother, 2008, 52(3): 1028-1033.
8. Orsi GB, García-Fernández A, Giordano A, et al. Risk factors and clinical significance of ertapenem-resistant Klebsiella pneumoniae in hospitalised patients[J]. J Hosp Infect, 2011, 78(1): 54-58.
9. Shilo S, Assous MV, Lachish T, et al. Risk factors for bacteriuria with carbapenem-resistant Klebsiella pneumoniae and its impact on mortality: A case-control study[J]. Infection, 2013, 41(2): 503-509.
10. Papadimitriou-Olivgeris M, Marangos M, Fligou F, et al. KPCproducing Klebsiella pneumoniae enteric colonization acquired during intensive care unit stay: The significance of risk factors for its development and its impact on mortality[J]. Diagn Microbiol Infect Dis, 2013, 77(2): 169-173.
11. Kofteridis DP, Valachis A, Dimopoulou D, et al. Risk factors for carbapenem-resistant Klebsiella pneumoniae infection/colonization: A case-case-control study[J]. J Infect Chemother, 2014, 20(5): 293-297.
12. Munoz-Price LS, Quinn JP. The spread of Klebsiella pneumonia carbapenemases: A tale of strains, plasmids, and transposons[J]. Clin Infect Dis, 2009, 49(11): 1739-1741.
13. Guh AY, Limbago BM, Kallen AJ. Epidemiology and prevention of carbapenem-resistant Enterobacteriaceae in the United States [J]. Expert Rev Anti Infect Ther, 2014, 12(5): 565-580.
14. Harris AD, Karchmer TB, Carmeli Y, et al. Methodological principles of caseecontrol studies that analyzed risk factors for antibiotic resistance: A systematic review [J]. Clin Infect Dis, 2001, 32(7): 1055-1061.